CDAK
Codiak Biosciences, Inc.
No insider bought or sold Codiak Biosciences, Inc. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
CDAK over the last year
Prices for CDAK aren't in yet.
CDAK after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
7 insider filings since 2021, newest first
CDAKBuy
Arch Venture Fund Viii, L.P. · 10% owner
$7.5M+130.0%Sep 15
CDAKBuy
Nicole Barna · Insider
$50KFeb 7
CDAKSell
Konstantin Konstantinov · CTO
$186K−100.0%Sep 28
CDAKSell
Benny Sorensen · Insider
$219K−100.0%Sep 28
CDAKSell
Sriram Sathyanarayanan · Chief Scientific Officer
$54K−100.0%Sep 28
CDAKBuy
Kyriazi Theo Melas · Director
$99KApr 30
CDAKBuy
Briggs Morrison · Director
$100KFeb 17
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.